Back to full study details
New York, NYNow Enrolling

B-cell Lymphoma Clinical Trial in New York, NY

Access cutting-edge b-cell lymphoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Expert Care

Access b-cell lymphoma specialists in New York at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related b-cell lymphoma treatment provided free

About This B-cell Lymphoma Study in New York

This is a Phase I/II study designed to evaluate if experimental T cell engaging antibody targeting CD20 AZD5492 is safe, tolerable and efficacious in participants with Relapsed or Refractory B-Cell Malignancies.

Sponsor: AstraZeneca

Apply for This New York Location

Check if you qualify for this b-cell lymphoma clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

B-cell Lymphoma Treatment Options in New York, NY

If you're searching for b-cell lymphoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Why Consider a Clinical Trial for B-cell Lymphoma?

  • Access to new treatments before they're widely available
  • Receive care from leading b-cell lymphoma specialists in New York
  • Contribute to medical research that could help future patients
  • Study-related care is typically provided at no cost
  • Close monitoring by a dedicated research team
  • Possible compensation for time and travel